Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
The Food and Drug Administration (FDA, the Agency, or we) is announcing a public meeting entitled "Increasing Access to Nonprescription Drugs." The purpose of the public meeting is to discuss perspectives from interested parties on increasing access to nonprescription drugs. We are also requesting comments.
Published
Apr 15, 2026
Comments Close
May 8, 2026(21d)
Citation
91 FR 20170
Agencies
2
Full text not available in our database.
View on Federal Register →Get a plain-English explanation of what this regulation does, which agencies are responsible, and how it affects existing rules.
No document text available yet
Docket No. FDA-2025-N-4731